Raymond James raises Dyne Therapeutics target price to $41 from $37
DYN•Raymond James raised its target price for Dyne Therapeutics to $41 from $37.
Related News
nVent expands manufacturing capacity with 400,000-square-foot Arizona facility
NVT•
Kratos buys AMCM metal 3D printing system to expand hypersonics manufacturing
KTOS•
BillionToOne to participate in UBS and Stifel healthcare conferences
BLLN•
RTX CFO Neil Mitchill to speak at Baird Global Industrial Conference
RTX•
Davion Healthcare acquires Humaskan medical technology IP for $25 million
DAVI•